Healthcare stocks with strong revenue growth and attractive valuations

What happened

A screen of healthcare stocks with strong year-over-year revenue growth highlighted nine companies ranked by Seeking Alpha Quant Valuation Grades. Harmony Biosciences and Ironwood Pharmaceuticals led with A+ grades and revenue growth of 24.25% and 26.19%, while CorMedix posted the highest growth at 280.50%.

Confirmed

Global impact / market context

Investors seeking growth at a reasonable price may use such screens to find healthcare companies whose revenue is rising faster than their valuations imply. The list spans biopharmaceuticals, specialty pharmaceuticals, healthcare services and biotechnology, so the opportunity set is broad.

Analyst inference

Drug development risks, legal and regulatory hurdles, and shifts in healthcare spending can all affect sector performance. Companies trading at discounts to their fundamentals may appeal to investors, but high revenue growth alone does not guarantee returns.

Analyst inference

What to watch

1. Harmony Biosciences and Ironwood Pharmaceuticals both earned A+ valuation grades, while Alignment Healthcare, Assembly Biosciences, CorMedix, Neurocrine Biosciences and Viemed Healthcare earned A grades. Confirmed
2. Investors could compare each company's revenue growth with its valuation grade to judge whether the growth is already reflected in the share price. Proposed
3. Regulatory hurdles and shifts in healthcare spending could hit revenue growth, so watch whether these companies sustain their reported year-over-year gains in later periods. Analyst inference

Evidence

• seekingalpha.com